Works about NON-alcoholic fatty liver disease
Results: 5000
Biochemical screen correction possibilities in patients with non-alcoholic fatty liver disease with diabetes mellitus.
- Published in:
- Regulatory Mechanisms in Biosystems, 2018, v. 9, n. 3, p. 384, doi. 10.15421/021857
- By:
- Publication type:
- Article
Andrographolide Inhibits the NF-κB Signaling Pathway and Alleviates High-Fat Diet-Induced Hepatic Inflammation in a Mouse Model of Nonalcoholic Fatty Liver Disease.
- Published in:
- Natural Product Communications, 2025, v. 20, n. 2, p. 1, doi. 10.1177/1934578X241302020
- By:
- Publication type:
- Article
Association Between Serum Zinc and Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis: NHANES 2011–2016: Association Between Serum Zinc and Non-Alcoholic Fatty Liver Disease and Advanced Liver Fibrosis: NHANES 2011–2016: M. Ye et al
- Published in:
- Biological Trace Element Research, 2025, v. 203, n. 3, p. 1305, doi. 10.1007/s12011-024-04261-x
- By:
- Publication type:
- Article
The effect of chitosan supplementation on liver function, hepatic steatosis predictors, and metabolic indicators in adults with non-alcoholic fatty liver disease: a randomized, double-blinded, placebo-controlled, clinical trial.
- Published in:
- Journal of Health, Population & Nutrition, 2025, v. 44, n. 1, p. 1, doi. 10.1186/s41043-025-00797-3
- By:
- Publication type:
- Article
The complex role of glycine N-methyltransferase in metabolism-a review.
- Published in:
- Molecular Biology Reports, 2025, v. 52, n. 1, p. 1, doi. 10.1007/s11033-025-10374-w
- By:
- Publication type:
- Article
Concentric remodeling and the metabolic-associated steatotic liver disease in patients with type 1 diabetes: an exploratory study.
- Published in:
- Acta Diabetologica, 2025, v. 62, n. 3, p. 385, doi. 10.1007/s00592-024-02365-3
- By:
- Publication type:
- Article
Associations between MASLD, atrial fibrillation, cardiovascular events, mortality and aspirin use in older adults.
- Published in:
- GeroScience, 2025, v. 47, n. 1, p. 1303, doi. 10.1007/s11357-024-01435-2
- By:
- Publication type:
- Article
Association between TyG-related parameters and NAFLD risk in Japanese non-obese population.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-88478-3
- By:
- Publication type:
- Article
Antioxidative Function of Zinc and Its Protection Against the Onset and Progression of Kidney Disease Due to Cadmium.
- Published in:
- Biomolecules (2218-273X), 2025, v. 15, n. 2, p. 183, doi. 10.3390/biom15020183
- By:
- Publication type:
- Article
Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease.
- Published in:
- Pharmaceuticals (14248247), 2025, v. 18, n. 2, p. 279, doi. 10.3390/ph18020279
- By:
- Publication type:
- Article
EFFECT OF S-ADENOSYLMETHIONINE ON HEPATIC AND METABOLIC DISORDERS IN GUINEA PIGS WITH NON-ALCOHOLIC STEATOHEPATITIS.
- Published in:
- Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2025, v. 88, n. 1, p. 60, doi. 10.26650/IUITFD.1498606
- By:
- Publication type:
- Article
Editorial: Immunesenescence in innate immune cells and disease development.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1563373
- By:
- Publication type:
- Article
Obesity: A Global Health Challenge Demanding Urgent Action.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 502, doi. 10.3390/biomedicines13020502
- By:
- Publication type:
- Article
Therapeutic Targets and Approaches to Manage Inflammation of NAFLD.
- Published in:
- Biomedicines, 2025, v. 13, n. 2, p. 393, doi. 10.3390/biomedicines13020393
- By:
- Publication type:
- Article
The Risk of Metabolic Dysfunction-Associated Steatotic Liver Disease in Moderate-to-Severe Psoriasis: A Systematic Review and Meta-Analysis.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1374, doi. 10.3390/jcm14041374
- By:
- Publication type:
- Article
Persistently Active Helicobacter pylori Infection Is Associated with the Development of Metabolic Dysfunction-Associated Steatotic Liver Disease.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1073, doi. 10.3390/jcm14041073
- By:
- Publication type:
- Article
Hepatotoxicity in Carp (Carassius auratus) Exposed to Perfluorooctane Sulfonate (PFOS): Integrative Histopathology and Transcriptomics Analysis.
- Published in:
- Animals (2076-2615), 2025, v. 15, n. 4, p. 610, doi. 10.3390/ani15040610
- By:
- Publication type:
- Article
Hypothyroidism/subclinical hypothyroidism and metabolic dysfunction-associated steatotic liver disease: advances in mechanism and treatment.
- Published in:
- Lipids in Health & Disease, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12944-025-02474-0
- By:
- Publication type:
- Article
Xiaohua Funing decoction ameliorates non-alcoholic fatty liver disease by modulating the gut microbiota and bile acids.
- Published in:
- Frontiers in Microbiology, 2025, p. 1, doi. 10.3389/fmicb.2025.1511885
- By:
- Publication type:
- Article
Muscle Strength and Cardiovascular Health in MASLD: A Prospective Study.
- Published in:
- Medicina (1010660X), 2025, v. 61, n. 2, p. 247, doi. 10.3390/medicina61020247
- By:
- Publication type:
- Article
Antioxidant Peptides from Miiuy Croaker Swim Bladders: Ameliorating Effect and Mechanism in NAFLD Cell Model through Regulation of Hypolipidemic and Antioxidant Capacity.
- Published in:
- Marine Drugs, 2025, v. 23, n. 2, p. 63, doi. 10.3390/md23020063
- By:
- Publication type:
- Article
Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1778, doi. 10.3390/ijms26041778
- By:
- Publication type:
- Article
Microbiota and Inflammatory Markers: A Review of Their Interplay, Clinical Implications, and Metabolic Disorders.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1773, doi. 10.3390/ijms26041773
- By:
- Publication type:
- Article
Unraveling Metabolic Dysfunction-Associated Steatotic Liver Disease Through the Use of Omics Technologies.
- Published in:
- International Journal of Molecular Sciences, 2025, v. 26, n. 4, p. 1589, doi. 10.3390/ijms26041589
- By:
- Publication type:
- Article
Detecting severe coronary artery stenosis in T2DM patients with NAFLD using cardiac fat radiomics-based machine learning.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-91523-w
- By:
- Publication type:
- Article
Exploring the nexus between hypothyroidism and metabolic dysfunction-associated steatotic liver disease: a UK biobank cohort study.
- Published in:
- Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-91221-7
- By:
- Publication type:
- Article
Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management.
- Published in:
- Metabolites (2218-1989), 2025, v. 15, n. 2, p. 127, doi. 10.3390/metabo15020127
- By:
- Publication type:
- Article
Lipid Biomarkers and Cardiometabolic Diseases: Critical Knowledge Gaps and Future Research Directions.
- Published in:
- Metabolites (2218-1989), 2025, v. 15, n. 2, p. 108, doi. 10.3390/metabo15020108
- By:
- Publication type:
- Article
Effectiveness of Pemafibrate Dose Escalation on Metabolic Dysfunction-Associated Steatotic Liver Disease Refractory to Standard Dose.
- Published in:
- Metabolites (2218-1989), 2025, v. 15, n. 2, p. 100, doi. 10.3390/metabo15020100
- By:
- Publication type:
- Article
Fructose Intake and Unhealthy Eating Habits Are Associated with MASLD in Pediatric Obesity: A Cross-Sectional Pilot Study.
- Published in:
- Nutrients, 2025, v. 17, n. 4, p. 631, doi. 10.3390/nu17040631
- By:
- Publication type:
- Article
Reactive Dicarbonyl Scavenging with 2-Hydroxybenzylamine Improves MASH.
- Published in:
- Nutrients, 2025, v. 17, n. 4, p. 610, doi. 10.3390/nu17040610
- By:
- Publication type:
- Article
Metabolic Dysfunction-Associated Steatotic Liver Disease vs. Metabolic Dysfunction-Associated Fatty Liver Disease: Which Option is the Better Choice?
- Published in:
- British Journal of Hospital Medicine (17508460), 2025, v. 86, n. 2, p. 1, doi. 10.12968/hmed.2024.0754
- By:
- Publication type:
- Article
Differential Exercise Requirements for Nonalcoholic Fatty Liver Disease Resolution Across Age Groups: A Longitudinal Study of Korean Military Officers.
- Published in:
- Journal of Physical Activity & Health, 2025, v. 22, n. 3, p. 323, doi. 10.1123/jpah.2024-0334
- By:
- Publication type:
- Article
A multicentre, multinational study of clinical characteristics and prognosis of hepatocellular carcinoma.
- Published in:
- Eastern Mediterranean Health Journal, 2023, v. 29, n. 6, p. 462, doi. 10.26719/emhj.23.087
- By:
- Publication type:
- Article
A population-based study of obesity and its complications in southern Islamic Republic of Iran.
- Published in:
- Eastern Mediterranean Health Journal, 2023, v. 29, n. 2, p. 100, doi. 10.26719/emhj.23.014
- By:
- Publication type:
- Article
Association between polypharmacy, patient-reported symptoms, and quality of life among nonalcoholic fatty liver disease patients in the United States.
- Published in:
- Drugs & Therapy Perspectives, 2022, v. 38, n. 11, p. 490, doi. 10.1007/s40267-022-00957-z
- By:
- Publication type:
- Article
An ER‐targeted, Viscosity‐sensitive Hemicyanine Dye for the Diagnosis of Nonalcoholic Fatty Liver and Photodynamic Cancer Therapy by Activating Pyroptosis Pathway.
- Published in:
- Angewandte Chemie, 2024, v. 136, n. 9, p. 1, doi. 10.1002/ange.202316487
- By:
- Publication type:
- Article
The Influence of the FFAR4 Agonist TUG-891 on Liver Steatosis in ApoE-Knockout Mice.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 4, p. 667, doi. 10.1007/s10557-023-07430-7
- By:
- Publication type:
- Article
Non-invasive fibrosis assessments of non-alcoholic fatty liver disease associated with low estimated glomerular filtration rate among CKD patients: the Fukuoka Kidney disease Registry Study.
- Published in:
- Clinical & Experimental Nephrology, 2021, v. 25, n. 8, p. 822, doi. 10.1007/s10157-020-02018-z
- By:
- Publication type:
- Article
Deep Contrast Clustering Analysis to Distinguish Diabetic Complications in Elderly Chinese Patients.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2024, v. 40, n. 7, p. 1, doi. 10.1002/dmrr.70000
- By:
- Publication type:
- Article
Letter: Statin use in patients with type 2 diabetes has lower risk of hip fractures.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2024, v. 40, n. 3, p. 1, doi. 10.1002/dmrr.3756
- By:
- Publication type:
- Article
TorS ‐ Reframing a rational for type 2 diabetes treatment.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2024, v. 40, n. 1, p. 1, doi. 10.1002/dmrr.3712
- By:
- Publication type:
- Article
Why do some glucose‐lowering agents improve non‐alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 7, p. 1, doi. 10.1002/dmrr.3668
- By:
- Publication type:
- Article
Low 25 (OH) vitamin D levels are associated with increased prevalence of nonalcoholic fatty liver disease and significant liver fibrosis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 5, p. 1, doi. 10.1002/dmrr.3628
- By:
- Publication type:
- Article
Glucagon in type 2 diabetes: Friend or foe?
- Published in:
- Diabetes/Metabolism Research & Reviews, 2023, v. 39, n. 3, p. 1, doi. 10.1002/dmrr.3609
- By:
- Publication type:
- Article
A novel model for detecting advanced fibrosis in patients with nonalcoholic fatty liver disease.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2022, v. 38, n. 8, p. 1, doi. 10.1002/dmrr.3570
- By:
- Publication type:
- Article
Serum creatinine levels and risk of nonalcohol fatty liver disease in a middle‐aged and older Chinese population: A cross‐sectional analysis.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2022, v. 38, n. 2, p. 1, doi. 10.1002/dmrr.3489
- By:
- Publication type:
- Article
Advanced liver fibrosis and the metabolic syndrome in a primary care setting.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 8, p. 1, doi. 10.1002/dmrr.3452
- By:
- Publication type:
- Article
Effects of sodium‐glucose co‐transporter 2 inhibitors on liver parameters and steatosis: A meta‐analysis of randomized clinical trials.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 6, p. 1, doi. 10.1002/dmrr.3413
- By:
- Publication type:
- Article
NAFLD in type 2 diabetes mellitus: Still many challenging questions.
- Published in:
- Diabetes/Metabolism Research & Reviews, 2021, v. 37, n. 2, p. 1, doi. 10.1002/dmrr.3386
- By:
- Publication type:
- Article